Idera Pharmaceuticals reported $4.74M in Current Liabilities for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Agenus AGEN:US $ 159.72M 3.34M
Alnylam Pharmaceuticals ALNY:US $ 657.68M 51.72M
Amgen AMGN:US $ 12618M 268M
Biogen BIIB:US $ 5018M 1071.4M
Biomarin Pharmaceutical BMRN:US $ 464.73M 25.69M
Cytrx CYTR:US 3.1M 633.56K
Dynavax Technologies DVAX:US $ 345.2M 121M
Eli Lilly And LLY:US $ 15620.6M 2234.6M
Gilead Sciences GILD:US $ 9220M 662M
GlaxoSmithKline GSK:LN 3783500M 1355700M
Idera Pharmaceuticals IDRA:US $ 4.74M 0.94M
Mirati Therapeutics MRTX:US $ 119.15M 4.42M
Nektar Therapeutics NKTR:US $ 104.98M 0.3M
Sarepta Therapeutics SRPT:US $ 545.57M 90.6M
Seattle Genetics SGEN:US $ 608.52M 77.23M
Ultragenyx Pharmaceutical RARE:US $ 220.64M 53.4M